Biotech Startups Get a Boost: ZAGENO and Hatch.Bio Labs Partner to Streamline Lab Operations Jan 08, 2025 22:30 HKT/SGT Read More
Elucidation of part of the Mechanism by which Lecanemab Slows the Progression of Alzheimer's Disease Jan 07, 2025 08:14 HKT/SGT Read More
Everest Medicines Announces the Implementation of NEFECON National Reimbursement Drug List Pricing in China for the Treatment for IgA Nephropathy Jan 02, 2025 10:52 HKT/SGT Read More
Fujirebio and Eisai Enter into Memorandum of Understanding for Joint Research and Social Implementation of Blood-based Biomarkers in the Field of Neurodegenerative Diseases Dec 23, 2024 16:22 HKT/SGT Read More
Everest Medicines Announces the First Prescription of VELSIPITY(R) in the Greater Bay Area Dec 18, 2024 14:29 HKT/SGT Read More
Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY Dec 17, 2024 10:58 HKT/SGT Read More
CIL Announces Breakthrough in Benzene Recovery, Addressing Cost, Environmental, and Supply Challenges for OLED Display Manufacturers Dec 12, 2024 22:00 HKT/SGT Read More
Everest Medicines Announces the First Prescription of VELSIPITY(R) Issued in Macau Dec 12, 2024 12:11 HKT/SGT Read More
VisiRose Introduces Revolutionary Therapy for Severe Eye Infections Dec 10, 2024 20:30 HKT/SGT Read More
"LEQEMBI" (Lecanemab) Approved for the Treatment of Early Alzheimer's Disease in Mexico Dec 05, 2024 10:22 HKT/SGT Read More